
Trio of new medicines originate from Scripps Research discoveries
March 26, 2019
La Jolla, CA - While billions of investment dollars pour into pharmaceutical development in the biotechnology and pharmaceutical industry sector each year, centers of academic excellence remain the birthplace of innovative discoveries that enable novel treatment strategies addressing the world's most dire unmet medical needs.
Scripps Research is doubling down on its legacy of discovery biology that is translated into much-needed new medicines within the boundaries of Scripps Research, a track-record exemplified by a trio of new drugs making their way to the marketplace.
The pharmaceutical company Celgene announced Monday that it filed an application with the U.S. Food and Drug Administration seeking approval to treat multiple sclerosis (MS) with ozanimod, a drug invented by Scripps Research professors Hugh Rosen, MD, PhD, and Edward Roberts, PhD.
In January, the FDA also accepted a drug application from Pfizer for the treatment of cardiomyopathy with tafamidis, a medicine invented by Scripps Research professors Jeffery Kelly, PhD, and Evan Powers, PhD. And in May of last year, individuals with a rare genetic disorder called phenylketonuria (PKU) received new hope with the FDA's approval of BioMarin's drug Palynziq , which was developed in collaboration with the Scripps Research laboratory of Raymond Stevens, PhD.
These three new drugs continue a long history of translating groundbreaking discoveries made at Scripps Research into new drugs used in the clinic, said Matt Tremblay, PhD, chief operating officer of Scripps Research and its drug discovery division, Calibr. They underscore the ability of our researchers to play a major role in creating new medicines.
Scripps Research has originated a total of nine approved drugs, from surfaxin, which helps premature babies take their first breaths, to humira, an inflammation-blocking antibody used to treat rheumatoid arthritis and other conditions.
Over the past two years, Scripps Research has greatly expanded its own in-house translational research capacity with the aim of advancing its medicines through clinical studies in patients and reinvesting revenues from those drugs back into research. Under the leadership of Peter Schultz, PhD, president and CEO, the institute has assembled a unique infrastructure by merging with two other entities: Calibr, a nonprofit drug discovery center with a pipeline of new medicines founded by Schultz in 2012; and the Scripps Research Translational Institute, founded by Eric Topol, MD, that focuses on personalizing medicine with the power of genomics, wireless digital technologies and artificial intelligence.
This new business model for nonprofit research institutes simultaneously fuels fundamental biomedical discoveries and speeds their translation into medicines by re-investing licensing revenues into ongoing basic and translational science. Ozanimod, tafamidis and Palynziq demonstrate how scientific insight into the biology underlying disorders are essential to developing therapies, and how that insight can be effectively paired with drug development expertise to have a significant impact on patients living with disease.
The seminal discovery that led to ozanimod was reported by Rosen and his team in Science in 2002. They showed that altering the activity of certain cellular receptors could dampen the effects of the immune system. Working with Roberts and other researchers, Rosen developed ozanimod, which binds to these receptors and inactivates immune system cells involved in MS and inflammatory bowel disease (IBD).
Celgene acquired the rights to ozanimod in 2015 and the application filing announced this week seeks approval to market the drug for relapsing and relapsing-remitting MS. At the same time, Phase 3 studies for ulcerative colitis, a form of IBD, are on track to be completed by mid-2020, resulting in a subsequent filing for approval in 2021.
The story of ozanimod and these other new therapies highlights the uniqueness of Scripps Research, Rosen says. There are hardly any other academic institutions in the world that have the multidisciplinary expertise to discover a new disease-modifying compound and generate clinical data in support of its development.
Tafamidis, conceived and synthesized in Kelly's lab and now exclusively licensed to Pfizer, has been approved in 40 countries for the treatment of familial amyloid polyneuropathy (FAP), a rare neurodegenerative disorder that results from transthyretin aggregation. Pfizer has also recently completed a tafamidis Phase 3 clinical trial in individuals with the heart disorder transthyretin amyloid cardiomyopathy, which affects a much larger population. Tafamidis demonstrated a significant reduction in the risk of all-cause mortality and cardiovascular-related hospitalizations. The FDA has granted fast track designation for considering approval of tafamidis for this condition, which leads to congestive heart failure and death within about five years of diagnosis if untreated.
The approval of Palynziq marked a watershed moment for people with PKU, a disorder that occurs in 1 in 10,000 to 15,000 births in the United States.
The therapy replaces a critical enzyme, phenylalanine hydroxylase (PAH), which breaks down phenylalanine, an amino acid found in most proteins and in ubiquitous artificial sweeteners resulting in significant dietary restrictions and life-threatening consequences for PKU patients, who lack the enzyme.
Stevens' research on the three-dimensional structure of the PAH enzyme alone or bound to drug candidates enabled a collaboration with BioMarin that ultimately led to Kuvan , the standard of care for mild PKU patients. By activating the metabolism of phenylalanine, Kuvan expands dietary options for about 40 percent of
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
16/11/2026
November 16, 2026
Hitachi system enables proton beams to be delivered from 360 degrees around the patient, expanding treatment capacity and supporting more pre...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Hiltron Communications has received a repeat order from one of Europes longest established communications satellite operators. Central to this project is a Hilt...
16/11/2026
Fabric Insights and Fonn Group today announce a partnership to connect editorial planning and media operations across their complementary product portfolios.
...
16/11/2026
Density 1.0 brings a complete color grading workflow to Final Cut Pro
Brie Clayton November 16, 2026
0 Comments
Filmmaker Pascal Basel's plugin pr...
16/11/2026
Berklee Students to Perform at Boston's CITGO Sign Relighting Kuper Walker, Ollie Mann, and dreamcorp. will perform at the free public celebration in Kenm...
16/11/2026
The Hollywood Reporter Names Berklee Among World's Best Music Schools The annual list spotlights Berklee's screen scoring programs and new master'...
16/11/2026
Five years ago, Lightware launched the original Taurus UCX with a clear vision: USB-C would become the central connection in meeting rooms. The goal was simple:...
16/11/2026
Sonniss: bundles over 80% below their libraries' prices, plus up to 60% off ...
16/11/2026
Singaporean Comedy Luck My Life Shot with Blackmagic URSA Cine 17K 65
Brie Clayton November 16, 2026
0 Comments
Blackmagic PYXIS 12K and DaVinci Resol...
16/11/2026
As countries gather to discuss climate targets at COP 31 this week, one question that is at the heart of debates is how to measure the environmental impact of t...
16/11/2026
Announced today at SC26, NVIDIA Rubin HPC is a new GPU in the NVIDIA Vera Rubin ...
16/11/2026
This week at SC26, NVIDIA is marking two decades of CUDA by honoring the researchers, developers and engineers who helped make GPU computing a foundation for mo...
16/11/2026
With expanded NVIDIA CUDA-X libraries, including cuPhoton, cuPotential and cuSpa, researchers can sift through vast amounts of data to accelerate research, from...
16/11/2026
In its MLPerf benchmarks debut, with results released today, the NVIDIA Vera Rub...
16/11/2026
Quantum processor deployments at supercomputing centers have grown nearly sevenfold over the past five years, with nearly 30 supercomputing centers around the w...
16/11/2026
To train an AI model, thousands of GPUs have to work together, requiring a network that's fast, efficient and resilient.
Lambda is tackling the network pie...
15/11/2026
Mixers, interfaces & DAW controller receive new firmware
Yamaha have just launched a trio of firmware updates that bring some powerful new functionality to ...
15/11/2026
Can VideoProc AI Really Reduce Noise and Enhance Blurry, Old Footage? Real-World...
15/11/2026
Over two days at COEX, more than 2,000 attendees converged for AI Day Seoul, bri...
14/11/2026
Longtime MLB Network employee David Maybrown passed away Thursday at the age of 57. David joined MLB Network in 2009 shortly after its launch, beginning as an i...
14/11/2026
Modular innovators introduce two guitar-based products
ADDAC System's recently introduced Four String Series makes it possible to integrate physical str...
14/11/2026
Marcelo Dai's Live Session Captured with URSA Cine Immersive
Brie Clayton November 14, 2026
0 Comments
Artist takes viewers on an immersive journe...
14/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
14/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
14/11/2026
Newest Lenses, Horizon Anamorphic Seminar & Guided Lens Character Experience Highlight Creative Possibilities
At the 2026 Toru CAMERIMAGE Film Festival, ZEISS...
14/11/2026
Sonnet Announces Black Friday Sale on Select Products
Brie Clayton November 14, 2026
0 Comments
WHAT: Sonnet Technologies is having a sale on a select...
14/11/2026
Berklee Alumni Shine at the 2026 Latin Grammy Awards This year's winners included songwriters, engineers, and performers who contributed to acclaimed reco...
13/11/2026
The UIM E1 Series wraps its third season this week with the Bombay Sapphire E1 Miami GP, Nov. 11-14, on Biscayne Bay at the Miami Seaplane Base on Watson Island...
13/11/2026
In-venue and creative video staffers at the professional and collegiate level ha...
13/11/2026
Singer-songwriter Benson Boone will headline entertainment for the Discover NHL Winter Classic between the Utah Mammoth and Colorado Avalanche at Rice-Eccles St...
13/11/2026
Blackmagic Design has announced the Blackmagic Ambisonic Microphone, a 7th order ambisonic microphone array that captures spatial audio for immersive video prod...
13/11/2026
SMPTE has announced that The Studio B&H and Riedel Communications will provide the video infrastructure and communications technology for the Solutions Hub at t...
13/11/2026
The Hollywood Professional Association (HPA) has announced the theme and program focus for the 2027 HPA Tech Retreat, which takes place Feb. 14-18, 2027, in La ...
13/11/2026
Football Manager 27 Touch is available on Apple Arcade starting today. The game ...
13/11/2026
MotoGP has announced a two-year media rights agreement with ESPN covering the Un...
13/11/2026
Apple Sports, the free iPhone app, has added the Ultimate Fighting Championship (UFC) to its lineup of supported sports, in time for Saturday's UFC 334. The...
13/11/2026
The NBA and Fanatics Studios, the joint venture between Fanatics and entertainme...
13/11/2026
ESPN held its annual EDGE Innovation Conference last night and offered up an ove...
13/11/2026
Regional sports network gives Ithaca College, SUNY Cortland students a platform to thrive
One of the biggest games in Division III college football will be pla...
13/11/2026
Studer-inspired 500-series PWM compressor unveiled
The HLabs range already includes a couple of Studer-inspired offerings in the form of the PRE169 and EQ16...